What is the current stock price of BriaCell Therapeutics Corp. (BCTXW)?

As of the latest market data, BriaCell Therapeutics Corp. (BCTXW) is trading at $0.00. The stock has seen a loss of -0.00% today.

Does BriaCell Therapeutics Corp. (BCTXW) pay a dividend?

Based on current data, BriaCell Therapeutics Corp. does not have a confirmed active dividend policy.

What is the market cap of BriaCell Therapeutics Corp.?

The current market capitalization of BriaCell Therapeutics Corp. (BCTXW) is approximately unavailable.

BCTXW

BriaCell Therapeutics Corp.·Healthcare

0.00

0.000%(−0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.06

Company Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2012-08-13

Beta

2.03

Websitebriacell.com↗